Correlation Between Aerovate Therapeutics and InMode
Can any of the company-specific risk be diversified away by investing in both Aerovate Therapeutics and InMode at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aerovate Therapeutics and InMode into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aerovate Therapeutics and InMode, you can compare the effects of market volatilities on Aerovate Therapeutics and InMode and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aerovate Therapeutics with a short position of InMode. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aerovate Therapeutics and InMode.
Diversification Opportunities for Aerovate Therapeutics and InMode
0.74 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Aerovate and InMode is 0.74. Overlapping area represents the amount of risk that can be diversified away by holding Aerovate Therapeutics and InMode in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on InMode and Aerovate Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aerovate Therapeutics are associated (or correlated) with InMode. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of InMode has no effect on the direction of Aerovate Therapeutics i.e., Aerovate Therapeutics and InMode go up and down completely randomly.
Pair Corralation between Aerovate Therapeutics and InMode
Given the investment horizon of 90 days Aerovate Therapeutics is expected to under-perform the InMode. But the stock apears to be less risky and, when comparing its historical volatility, Aerovate Therapeutics is 1.23 times less risky than InMode. The stock trades about -0.08 of its potential returns per unit of risk. The InMode is currently generating about -0.05 of returns per unit of risk over similar time horizon. If you would invest 1,926 in InMode on September 13, 2024 and sell it today you would lose (64.00) from holding InMode or give up 3.32% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 95.45% |
| Values | Daily Returns |
Aerovate Therapeutics vs. InMode
Performance |
| Timeline |
| Aerovate Therapeutics |
| InMode |
Aerovate Therapeutics and InMode Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Aerovate Therapeutics and InMode
The main advantage of trading using opposite Aerovate Therapeutics and InMode positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aerovate Therapeutics position performs unexpectedly, InMode can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in InMode will offset losses from the drop in InMode's long position.| Aerovate Therapeutics vs. Adagene | Aerovate Therapeutics vs. Acrivon Therapeutics, Common | Aerovate Therapeutics vs. Rezolute | Aerovate Therapeutics vs. AN2 Therapeutics |
| InMode vs. TransMedics Group | InMode vs. Inspire Medical Systems | InMode vs. Inari Medical | InMode vs. Insulet |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Other Complementary Tools
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |